Sunday, February 5, 2023
manilastandard.net
ADVERTISEMENT
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
manilastandard.net
No Result
View All Result
Home News Coronavirus 2019

Pharmaceutical firms rake in billions with COVID jabs

AFPbyAFP
August 10, 2021, 7:00 am
in Coronavirus 2019
Reading Time: 2 mins read
A A
Share on FacebookShare on TwitterShare on Email

COVID vaccines have brought billions of dollars to the coffers of pharmaceutical companies.

Germany's BioNTech, maker with partner Pfizer of the pioneering mRNA jab, raised its vaccine revenue forecast for 2021 in its latest earnings report on Monday.

Here are the numbers for the companies that publish financial results:

Biggest winners: Pfizer and BioNTech

US firm Pfizer and BioNTech got a headstart over rivals as they were the first in the western world to announce positive results from clinical trials of their vaccine last year.

ADVERTISEMENT

They were also first to get authorisation from US and European Union regulators to sell their shot.

Pfizer has earned more than its competitors, raking in $10.8 billion (9.2 billion euros) in the first half of this year.

The US company has raised its outlook for 2021, expecting to make $33.5 billion in sales for the full year.

BioNTech reported on Tuesday revenues of $7.3 billion euros in the first half. Unlike its larger partner, the company's only product on sale is the coronavirus vaccine.

BioNTech expects vaccine revenues to reach 15.9 billion euros for the full year, up from a previous estimate of 9.8 billion euros.

Moderna the other mRNA champion

US startup Moderna is the only other firm to have produced an authorised mRNA vaccine so far.

Messenger RNA technology works by providing human cells with the genetic instructions to make a surface protein of the coronavirus, which trains the immune system to recognise the real virus.

Like BioNTech, the company's only product in the market is the Covid vaccine. The vaccine requires two shots taken weeks apart.

Moderna reported turnover of $5.9 billion in the first six months of the year.

It expects to make $20 billion in revenues thanks to the vaccine this year.

AstraZeneca, Johnson & Johnson trail

British pharmaceutical giant AstraZeneca and US firm Johnson & Johnson had their vaccines approved by the EU later than their rivals.

AstraZeneca's vaccine is one of the world's leading vaccines and has been vital in the UK's speedy vaccination drive — which enabled England's economy to fully reopen this month.

But it has not been approved by US drug regulators.

Johnson & Johson's vaccine—made by Janssen, its Belgian subsidiary—has the advantage of being administered with one shot instead of two like those of its rivals.

AstraZeneca and J&J do not use mRNA technology. 

They both made more traditional viral vector vaccines, which use genetically-engineered version of a common-cold causing adenovirus as a "vector" to shuttle genetic instructions into human cells.

The two companies also vowed to sell their vaccines at cost during the pandemic, meaning they would not earn profits from them. 

They are cheaper than the Pfizer/BioNTech and Moderna jabs, which reflects in their revenues.

AstraZeneca's Covid jab generated $1.2 billion in sales in the first six months of the year. 

J&J reported $264 million in sales and expects to make $2.5 billion for the full year. AstraZeneca has not provided a detailed full-year estimate.

Julien Dury

Tags: BioNTechCOVID-19Pfizervaccines
ADVERTISEMENT
AFP

AFP

Related Posts

HK offers free flights after COVID isolation

byAFP
February 2, 2023, 6:15 pm
0
8
Taliban govt resumes issuing Afghan passports in Kabul

Hong Kong is ready to welcome the world back, its leader said Thursday, as he pitched free flights and positive...

Read more

NCR COVID positivity rate up slightly to 2.4%

byWillie Casas
January 29, 2023, 10:05 pm
0
8
PH logs 2 Omicron cases

The COVID-19 positivity rate in the National Capital Region (NCR) slightly increased to 2.4 percent on Friday, independent monitoring OCTA...

Read more

COVID slows down; WHO mulls
lowering alert level on pandemic

byManila Standard
January 29, 2023, 12:35 am
0
8
PH logs 2 Omicron cases

COVID-19 has significantly slowed down, but still kills thousands across the globe. The World Health Organization (WHO) has begun discussions—its...

Read more

China says Covid deaths down by nearly 80 percent

byAFP
January 26, 2023, 11:00 am
0
8
China says Covid deaths down by nearly 80 percent

The number of daily Covid-19 deaths in China has fallen by nearly 80 percent since the start of the month,...

Read more

WHO chief worried over COVID deaths

byWillie Casas
January 26, 2023, 1:10 am
0
8
Tedros in one-man race to remain at WHO helm

The World Health Organization (WHO) on Tuesday expressed concern over the increasing number of COVID-19 deaths worldwide. WHO Director-General Tedros...

Read more

Millions head home for China holidays, Xi flags COVID-19 worry

byAFP
January 19, 2023, 9:30 pm
0
8
EU tries to salvage ties with ex-Soviets

Tens of millions in China headed to their rural hometowns for Lunar New Year celebrations Thursday, though President Xi Jinping...

Read more

Print Edition

View More

Recent Posts

  • Up-and-coming singer hits listeners with new heartbreak anthem
  • ‘Agimat ng Agila’ is PMPC’s best drama series
  • Can Beyonce finally take home the top Grammy?
  • Queen of the arts
  • Vancouver… in Washington?
  • Rediscovering Makati’s hip and happening side 
  • Fall in love with City of Dreams’ seductive gastronomic offerings
  • IWF wins cement Diaz’s 3rd Athlete of Year award

Advertisement

Latest News

Rediscovering Makati’s hip and happening side 

byManila Standard Lifestyle
February 5, 2023, 8:40 pm
0
8
Fall in love with City of Dreams’ seductive gastronomic offerings

Noted for its numerous gated communities, upscale malls, world-class hotels, and bustling central business district, Makati City has a long-held...

Read more

Fall in love with City of Dreams’ seductive gastronomic offerings

byManila Standard Lifestyle
February 5, 2023, 8:30 pm
0
8
Fall in love with City of Dreams’ seductive gastronomic offerings

City of Dreams Manila highlights seductive offerings set to impress loved ones this Valentine’s season. For a swoon-worthy celebration, the...

Read more

IWF wins cement Diaz’s 3rd Athlete of Year award

byManila Standard Sports
February 5, 2023, 8:20 pm
0
8
All set for Army Navy Club200 Endurance Race on Feb. 11

Hidilyn Diaz is still dominant as ever. More than a year since giving the Philippines its first gold medal in...

Read more

Cavitex nails 1st PBA 3×3 title

byManila Standard Sports
February 5, 2023, 8:11 pm
0
8
Cavitex nails 1st PBA 3×3 title

LEG 4 of the PBA 3x3 belonged to Cavitex as it pulled off a 19-15 win against Pioneer Elastoseal for...

Read more

PNVF names men’s pool members ahead of camp

byManila Standard Sports
February 5, 2023, 8:10 pm
0
8
All set for Army Navy Club200 Endurance Race on Feb. 11

The Philippine National Volleyball Federation announced on Sunday the members of the national men’s pool from which the national team...

Read more

Advertisement

ADVERTISEMENT
Facebook Twitter Instagram Youtube

ABOUT US

Manila Standard

Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.

Digital Edition

In tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.

Download – Today’s Paper

Search

No Result
View All Result

6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines

Trunklines: 832-5554, 832-5556, 832-5558

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Pop.Life
    • Newsmakers
    • Hangouts
    • A-Pop
    • Post Its
    • Performances
    • Malls & Bazaars
    • Hobbies & Collections
  • Technology
    • Gadgets
    • Computers
    • Business
    • Tech Plus
  • MS ON THE ROAD
    • Sedan
    • SUV
    • Truck
    • Bike
    • Accessories
    • Motoring Plus
    • Commuter’s Corner
  • Home & Design
    • Residential
    • Commercial
    • Construction
    • Interior
  • Spotlight
  • Gallery
    • Photos
    • Videos
  • Events
    • Seminars
    • Exhibits
    • Community
  • Biyahero
    • Travel Features
    • Travel Reels
    • Travel Logs
  • Pets
  • Advertise with Us

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Install Manila Standard Web App

Install App